Identification of an AluY-mediated deletion of exon 5 in the CPOX gene by MLPA analysis in patients with hereditary coproporphyria

Authors

  • M Barbaro,

    1. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    2. Centre for Inherited Metabolic Diseases
    Search for more papers by this author
  • M Kotajärvi,

    1. Centre for Inherited Metabolic Diseases
    2. Porphyria Centre Sweden, Karolinska University Hospital, Stockholm, Sweden
    Search for more papers by this author
  • P Harper,

    1. Centre for Inherited Metabolic Diseases
    2. Porphyria Centre Sweden, Karolinska University Hospital, Stockholm, Sweden
    3. Department of Laboratory Medicine, Division of Metabolic Diseases, Karolinska Institutet, Stockholm, Sweden
    Search for more papers by this author
  • Y Floderus

    Corresponding author
    1. Centre for Inherited Metabolic Diseases
    2. Porphyria Centre Sweden, Karolinska University Hospital, Stockholm, Sweden
    3. Department of Laboratory Medicine, Division of Metabolic Diseases, Karolinska Institutet, Stockholm, Sweden
    Search for more papers by this author

Ylva Floderus, CMMS C2 71, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.
Tel.: +46 8 5858 2780;
fax: +46 8 5858 2760;
e-mail: ylva.floderus@karolinska.se

Abstract

Barbaro M, Kotajärvi M, Harper P, Floderus Y. Identification of an AluY-mediated deletion of exon 5 in the CPOX gene by MLPA analysis in patients with hereditary coproporphyria.

Hereditary coproporphyria (HCP) is an autosomal dominantly inherited hepatic porphyria, caused by a mutation in the coproporphyrinogen oxidase (CPOX) gene. The genetic defect leads to a partial defect of CPOX, the sixth enzyme involved in haem biosynthesis. Affected individuals can develop acute life-threatening attacks of neurovisceral symptoms and/or more rarely cutaneous symptoms such as skin fragility and blistering. The identification of the genetic defect in HCP families is of crucial importance to detect the carrier status which allows counselling to prevent possible triggering factors, e.g. certain drugs, alcohol, or fasting. In a total of nine Swedish HCP families, routine gene sequence analysis had identified a causative mutation in only five. In the present study, using an in-house developed synthetic probe set for multiplex ligation-dependent probe amplification (MLPA) analysis, we detected a deletion of the fifth exon in the CPOX gene in the remaining four families. The deletion is 3381 bp in size and has originated by an Alu-mediated mechanism. This finding emphasizes the usefulness of MLPA analysis as a complement to gene sequencing for comprehensive genetic diagnostics in HCP patients.

Ancillary